Monoclonal antibodies in haemato-oncology [electronic resource] / Mark Cragg.
Material type:
FilmSeries: Henry Stewart talksBiomedical & life sciences collection. Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances: Publisher: London : Henry Stewart Talks, 2020Description: 1 online resource (1 streaming video file (45 min.) : color, sound)Subject(s): Antineoplastic agents | Lymphoma -- Chemotherapy | Monoclonal antibodies | Antibodies, Monoclonal -- therapeutic use | Antineoplastic Agents -- pharmacology | Antineoplastic Agents, Immunological | B-Lymphocytes | Immunity, Cellular | Lymphoma -- drug therapy | Macrophages | obinutuzumab | Receptors, IgG -- drug effects | Receptors, IgG -- metabolism | Rituximab -- phamacologyOnline resources: Click here to access online | Series Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Introduction to the development and clinical use of monoclonal antibodies (mAb) in haemato-oncology -- Currently approved mAb for treating cancer -- Direct targeting antibodies -- Rituximab -- Fc gamma receptors (FcgR) as key mediators of cellular immunity -- Macrophages as key effector cells -- B cell deletion as a paradigm for mAb effects -- Type I versus Type II antibodies -- Obinutuzumab -- Immunomodulatory mAb -- Combinations between direct targeting and immunomodulatory mAb.
Access restricted to subscribers.
Mode of access: World Wide Web.